LOS ANGELES CAPITAL MANAGEMENT LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1177206 LOS ANGELES, CA

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,247,764

+$2,466,338 QoQ

Shares Held

50,786

+212.9% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#77

of 264 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 33% Shared 0% None 67%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $64,712,202 across 30 Drug Manufacturers - Specialty & Generic names. KNSA ranks #4 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	203,548	$34,305,979
2	VTRS	Viatris Inc	751,406	$11,932,327
3	LQDA	Liquidia Corp	54,603	$4,353,497
4	KNSA	Kiniksa Pharmaceuticals International, plc This page	50,786	$3,247,764
5	COLL	Collegium Pharmaceutical, Inc	89,443	$3,237,836
6	PAHC	Phibro Animal Health Corp	67,083	$2,106,406
7	IRWD	Ironwood Pharmaceuticals Inc	342,293	$1,441,053
8	AKBA	Akebia Therapeutics, Inc.	531,813	$606,266

All Filings in KNSA

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,247,764	50,786	+212.9%	Shares	Sole	2026-08-13
2026-03-31	$781,426	16,229	-31.4%	Shares	Sole	2026-05-08
2025-12-31	$975,933	23,659	+29.4%	Shares	Sole	2026-02-11
2025-09-30	$709,928	18,283	+127.5%	Shares	Sole	2025-10-20
2025-06-30	$222,383	8,037	-82.0%	Shares	Sole	2025-08-07
2025-03-31	$990,721	44,607	-19.7%	Shares	Sole	2025-05-05
2024-12-31	$1,098,343	55,528	-44.5%	Shares	Sole	2025-02-04
2024-09-30	$2,499,024	100,001	+26.3%	Shares	Sole	2024-11-04
2024-06-30	$1,478,664	79,200	—	Shares	Sole	2024-08-05
No filing history on record for this holder in this stock.